|
CN104072590A
|
|
Meningococcus antigen combination and application thereof
|
|
CN105198999A
|
|
Fusion protein and its preparation method and use
|
|
CN104250299A
|
|
Preparation method of human blood coagulation factor VIII
|
|
CN104056276A
|
|
Influenza virus attenuated live vaccine and preparation method thereof
|
|
CN104059873A
|
|
Non-tumorigenic MDCK cell line used for amplifying influenza viruses and screening method thereof
|
|
CN103849601A
|
|
Method for inducing transdifferentiation of fibroblasts into neuronal cells and application thereof
|
|
CN102824635A
|
|
Application of chitosan as adjuvant in preparation of influenza virus attenuated live vaccine
|
|
CN102839186A
|
|
Preparation and application of recombinant Mycobacterium smegmatis expressing NY-ESO-1
|
|
CN102465137A
|
|
Pichia pastoris for expressing rotavirus expression particles as well as preparation method and application of pichia pastoris
|
|
CN102453091A
|
|
Tetanus toxoid monoclonal antibody and preparation method and application thereof
|
|
CN102443594A
|
|
Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
|
